Open access
Aug 2026
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses
F4-Fc demonstrates prophylactic and therapeutic efficacy against influenza A and B viruses, representing a promising antiviral drug candidate for influenza virus infection and demonstrating its antiviral efficacy in vitro and protective activity in vivo.
Dong-Lan Liu, Yuxuan Zhang, Min Zhang et al.
· Journal of Virology · 0 citations